Analysis of the Effectiveness of Coordinated Care in the Management of Pharmacotherapy of Patients with Hypertension and Comorbidities in Primary Care-Preliminary Reports.
Aleksandra GalicAnna Tyrańska-FobkeAleksandra KuichAndrzej ZapasnikMarlena RobakowskaPublished in: Healthcare (Basel, Switzerland) (2024)
Hypertension (HTN) is the dominant cause of cardiovascular disease and premature death worldwide. Also in Poland, the number of people with HTN is steadily increasing. In order to improve care for patients with HTN and other chronic diseases, a pilot of the POZ PLUS coordinated-care model was introduced. The pilot ran from 1 July 2018 to 30 September 2021 at 47 facilities nationwide. The purpose of this study was to conduct a preliminary analysis of the effectiveness of this model of care. The study focused on the management of pharmacotherapy in patients with hypertension and other comorbidities. The study included a group of 90 patients with HTN. Fifty-nine people were in the coordinated-care study group and 31 in the control group. Data were collected from electronic medical records. The analysis showed a trend toward greater blood-pressure reduction in patients under coordinated care (-4 mmHg difference in systolic blood pressure between the second and first visits and -2 mmHg difference in diastolic pressure between the second and first visits, p = 0.180 and p = 0.156). This suggests the preliminary conclusion that coordinated care in the PCP plus model might have positively affected the outcomes of patients with HTN. Further studies on the subject are planned.
Keyphrases
- blood pressure
- healthcare
- palliative care
- primary care
- cardiovascular disease
- quality improvement
- randomized controlled trial
- heart failure
- pain management
- left ventricular
- affordable care act
- type diabetes
- chronic kidney disease
- clinical trial
- newly diagnosed
- heart rate
- insulin resistance
- coronary artery disease
- chronic pain
- atrial fibrillation
- adipose tissue
- deep learning
- smoking cessation
- study protocol
- electronic health record
- cardiovascular risk factors
- adverse drug
- finite element